Biography of Srini Ramanathan
Last update: 7 days agoCareer
Srini was Senior Vice President at Horizon, and Senior Director, Head of Clinical Pharmacology at Gilead Sciences. Srini Ramanathan joined Sumitomo Chemical in 2022.
Srini Ramanathan is currently- Chief Development Officer at Roivant Sciences - View - Roivant Sciences org chart
- Chief Development Officer at Telavant - View - Telavant org chart
Create your alert
to follow the career of Srini Ramanathan.
Education
In 2001, Srini Ramanathan completed a Doctor of Philosophy in Pharmaceutics at Rutgers University.
They have also studied at Rutgers University :
Find more alumni from Rutgers University
More about Srini Ramanathan
Selected links
Do you need to know more about Srini Ramanathan? More results.
Participate
Social media
- Srini Ramanathan on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Srini Ramanathan
The colleagues of Srini Ramanathan
Company Colleagues
- At Roivant Sciences, Srini Ramanathan has 306 colleagues including Matthew Gline (CEO), James Momtazee (Director)…
- At Telavant, Srini Ramanathan has 4 colleagues including Frank Torti (CEO & Director), Bittoo Kanwar (Medical)…
Homonyms
- Srinivas Ramanathan - Founder, President and Chief Executive Officer - eG Innovations
Industry Colleagues
- In the Biotechnology industry, Srini Ramanathan has 30,497 colleagues in 2,296 companies located in 40 countries. 14,287 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Srini Ramanathan.
Get in Touch
and ask for Srini Ramanathan.
